These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6142310)

  • 21. Post-transplantation lymphoproliferative disorder and OKT3.
    N Engl J Med; 1991 May; 324(20):1437-9. PubMed ID: 2020303
    [No Abstract]   [Full Text] [Related]  

  • 22. Isolated central nervous system Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.
    Watanabe A; Yoshida S; Kasahara Y; Takachi T; Ogawa A; Asami K
    Pediatr Blood Cancer; 2011 May; 56(5):871-2. PubMed ID: 21370426
    [No Abstract]   [Full Text] [Related]  

  • 23. [Post-transplant lymphoproliferative disorders in renal transplantation: two decades of experience].
    Franco A; Jiménez L; Sillero C; Trigueros M; González D; Alcaraz E; Olivares J
    Nefrologia; 2010; 30(6):669-75. PubMed ID: 21113217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances.
    Scarsbrook AF; Warakaulle DR; Dattani M; Traill Z
    Clin Radiol; 2005 Jan; 60(1):47-55. PubMed ID: 15642292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
    Walker RC; Paya CV; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; Daly RC; McGregor CG
    J Heart Lung Transplant; 1995; 14(2):214-21. PubMed ID: 7779838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hematologic malignant complications after transplantation].
    Caillard S; Imhoff O; Moulin B
    Nephrol Ther; 2011 Nov; 7(6):500-12. PubMed ID: 21531185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.
    Swinnen LJ; Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson MR; Heroux AL; Dizikes GJ; Pifarre R; Fisher RI
    N Engl J Med; 1990 Dec; 323(25):1723-8. PubMed ID: 2100991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging of post-transplant spindle cell tumors.
    Pollock AN; Newman B; Putnam PE; Dickman PS; Medina JL
    Pediatr Radiol; 1995 Nov; 25 Suppl 1():S118-21. PubMed ID: 8577501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphoproliferative disorders and hematologic malignancies following organ transplantation.
    Ferry JA; Jacobson JO; Conti D; Delmonico F; Harris NL
    Mod Pathol; 1989 Nov; 2(6):583-92. PubMed ID: 2587566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus--oncogen or mitogen?
    Schwartz RS
    N Engl J Med; 1980 Jun; 302(23):1307-8. PubMed ID: 6245366
    [No Abstract]   [Full Text] [Related]  

  • 31. [Presentation of cancers in recipients of a solid-organ transplant].
    Lampreabe I; Gómez-Ullate P; Amenábar JJ; Zárraga S; Gaínza FJ; Urbizu JM
    Nefrologia; 2001; 21(6):528-37. PubMed ID: 11881422
    [No Abstract]   [Full Text] [Related]  

  • 32. Chronic antigenic stimulation, herpesvirus infection, and cancer in transplant recipients.
    Matas AJ; Simmons RL; Najarian JS
    Lancet; 1975 Jun; 1(7919):1277-9. PubMed ID: 48901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unusual lymphoproliferative oropharyngeal lesions in heart and heart-lung transplant recipients.
    Fairley JW; Hunt BJ; Glover GW; Radley-Smith RC; Yacoub MH
    J Laryngol Otol; 1990 Sep; 104(9):720-4. PubMed ID: 2230584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants].
    Hidalgo M; Lumbreras C; Aguado JM
    Med Clin (Barc); 1996 Sep; 107(8):310-6. PubMed ID: 8965496
    [No Abstract]   [Full Text] [Related]  

  • 35. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.
    Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW
    Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas.
    Cleary ML; Sklar J
    Lancet; 1984 Sep; 2(8401):489-93. PubMed ID: 6147550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Infection by viruses of the herpes group in patients with renal transplants].
    Pannuti CS; Carvalho RP; Amato Neto V; Sabraga E; Angelo MJ
    Rev Inst Med Trop Sao Paulo; 1978; 20(6):353-8. PubMed ID: 220698
    [No Abstract]   [Full Text] [Related]  

  • 39. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
    Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G
    Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
    [No Abstract]   [Full Text] [Related]  

  • 40. Susceptibility of common marmosets (Callithrix jacchus) to oncogenic and attenuated strains of Herpesvirus saimiri.
    Wright J; Falk LA; Wolfe LG; Ogden J; Deinhardt F
    J Natl Cancer Inst; 1977 Nov; 59(5):1475-8. PubMed ID: 198565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.